Updates from Developmental Medicine & Child Neurology – October 2021
Please see below for the latest updates from DMCN and highlights from our latest issue.
Pre-orders are now open for the forthcoming title Children with Vision Impairment: Assessment, Development, and Management by Dale, Salt, Sargent and Geenaway. This title promises to provide key insight and guidance for practitioners, so pre-order now to secure your copy!
In DMCN news, we have a two-part review from Hart et al. looking at antenatal counselling around risk to parents of fetuses with neurological anomalies, plus a podcast from Allison Gregory discussing her paper. In case you missed it, be sure to check out the invited editorial from her majesty Queen Mathilde of Belgium, which is available in four languages.
Key papers published this month
Interventions to improve physical function for children and young people with cerebral palsy: international clinical practice guideline
This clinical practice guide by Jackman et al. provides 13 recommendations based on expert panel consensus and consumer consultation for interventions to improve physical function for children with cerebral palsy.
Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 1, experiences and recommendations for service design
The first part of this comprehensive two-part review by Hart et al. discusses the published evidence on antenatal counselling and recommendations for explaining risk to parents of fetuses with neurological anomalies. From this, the authors make recommendations for the organization of antenatal counselling services.
Part 2, risks of adverse outcome in common anomalies
Part 2 documents the risks of adverse outcome in common anomalies such as ventriculomegaly, cortical anomalies, microcephaly, macrocephaly, agenesis of the corpus callosum, posterior fossa anomalies, and myelomeningocele, to assist healthcare professionals in counselling.
Allison Gregory discusses her paper Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration.
The team at Mac Keith Press